Kura Oncology | 10-Q: Q3 2024 Earnings Report
Kura Oncology | 8-K: Kura Oncology Reports Third Quarter 2024 Financial Results
Kura Oncology | 3: Initial statement of beneficial ownership of securities-Director VASCONCELLES MICHAEL
Kura Oncology | 4: Statement of changes in beneficial ownership of securities-Director VASCONCELLES MICHAEL
Kura Oncology | 8-K: Current report
Kura Oncology | 10-Q: Q2 2024 Earnings Report
Kura Oncology | 8-K: Kura Oncology Reports Second Quarter 2024 Financial Results
Kura Oncology | 4: Statement of changes in beneficial ownership of securities-Director Collins Helen Louise
Kura Oncology | 4: Statement of changes in beneficial ownership of securities-Director Malley Thomas
Kura Oncology | 4: Statement of changes in beneficial ownership of securities-Director SCHAFER CAROL
Kura Oncology | 4: Statement of changes in beneficial ownership of securities-Director Parks Diane L.
Kura Oncology | 4: Statement of changes in beneficial ownership of securities-Director Hasnain Faheem
Kura Oncology | 4: Statement of changes in beneficial ownership of securities-Director Szela Mary T
Kura Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Kura Oncology | 8-K: Current report
Kura Oncology | 8-K: Current report
Kura Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Bair Teresa Brophy
Kura Oncology | 144: Notice of proposed sale of securities pursuant to Rule 144
Kura Oncology | SC 13G: Statement of acquisition of beneficial ownership by individuals
Kura Oncology | 10-Q: Q1 2024 Earnings Report
No Data
No Data